Why Changes are needed to Current Preformulation and Formulation Practices
Add bookmark
Why Changes are needed to Current Preformulation and Formulation Practices
Add bookmark
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development. Horspool also shares his top 3 tips for evaluating the potential of new drug delivery techno...
Tags:
Keith Horspool
Boehringer Ingelheim
co-crystals
preformulation
Formulation
Pharma Leaders Today
R&D
R&D process
formulation design
product development
formulation practices
pharmaceutical development
drug delivery technologies
drug delivery
